Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.
about
Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Valaciclovir to prevent Cytome ...... a randomised controlled trial.
@en
Valaciclovir to prevent Cytome ...... in ANCA-associated vasculitis
@nl
type
label
Valaciclovir to prevent Cytome ...... a randomised controlled trial.
@en
Valaciclovir to prevent Cytome ...... in ANCA-associated vasculitis
@nl
prefLabel
Valaciclovir to prevent Cytome ...... a randomised controlled trial.
@en
Valaciclovir to prevent Cytome ...... in ANCA-associated vasculitis
@nl
P2093
P2860
P1433
P1476
Valaciclovir to prevent Cytome ...... a randomised controlled trial
@en
P2093
Dimitrios Chanouzas
Lovesh Dyall
Matthew David Morgan
Peter Nightingale
P2860
P2888
P356
10.1186/S13063-016-1482-2
P577
2016-07-22T00:00:00Z
P6179
1005602283